Hannah Campbell Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
unknown
Research Areas
Biography and Research Information
OverviewAI-generated summary
Hannah Campbell's research investigates the genetic underpinnings of inflammation and its association with chronic diseases. Her work has explored the link between genetically determined NLRP3 inflammasome activation and systemic inflammation, as well as its correlation with cardiovascular mortality. Campbell has also contributed to understanding metabolic disorders, specifically type 2 diabetes, through a genetic lens. Her research interests extend to developing and assessing methods for evaluating physiological functions, such as balance and postural sway in conditions like hypermobile Ehlers-Danlos syndrome. Additionally, she has been involved in research concerning genome editing for the treatment of cardiac conditions like catecholaminergic polymorphic ventricular tachycardia. Campbell's scholarly contributions include 8 publications with 190 citations and an h-index of 4. She collaborates with Thomas Lowder at the University of Central Arkansas.
Metrics
- h-index: 4
- Publications: 8
- Citations: 192
Selected Publications
-
A novel method of assessing balance and postural sway in patients with hypermobile Ehlers-Danlos syndrome (2023)
Collaboration Network
Top Collaborators
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
Similar Researchers
Based on overlapping research topics